HALO VISION side effect
What is HALO VISION ?HALO VISION : Enbrel Side Effects Report #5546639-1
Physician from UNITED STATES reported ENBREL problem on Feb 14, 2007. Male patient, weighting 268.3 lb, was diagnosed with psoriatic arthropathy and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: halo vision, . ENBREL dosage: unknown. During the same period patient was treated with METHOTREXATE, DICLOFENAC, VITAMIN CAP, SUDAFED. Patient recovered.
HALO VISION : Visine Side Effects Report #5663713-X
VISINE A problem was reported by a Consumer or non-health professional from UNITED STATES on Feb 27, 2008. Male patient, 55 years of age, weighting 269.0 lb, was diagnosed with eye disorder and was treated with VISINE A. After drug was administered, patient experienced the following problems/side effects: eye irritation, halo vision, vision blurred, . VISINE A dosage: unknown. During the same period patient was treated with ACTOS. Patient recovered.
HALO VISION : Requip Side Effects Report #5465591-0
Consumer or non-health professional from UNITED STATES reported REQUIP problem on Sept 19, 2007. Female patient, 46 years of age, weighting 125.0 lb, was diagnosed with restless legs syndrome and was treated with REQUIP. After drug was administered, patient experienced the following problems/side effects: asthenopia, halo vision, headache, vision blurred, visual disturbance, . REQUIP dosage: 1 MG AT BEDTIME PO. During the same period patient was treated with IRBESARTAN, FOLIC ACID, LEVOTHYROXINE, SERTRALINE, SIMAVISTATIN, FIORICET, OXYCODONE. Patient recovered.
HALO VISION : Carbidopa Side Effects Report #5678815-1
CARBIDOPA AND LEVODOPA problem was reported by a Consumer or non-health professional from UNITED STATES on Mar 14, 2008. Female patient, 70 years of age, was diagnosed with parkinson's disease and was treated with CARBIDOPA AND LEVODOPA. After drug was administered, patient experienced the following problems/side effects: condition aggravated, halo vision, parkinsonism, visual disturbance, . CARBIDOPA AND LEVODOPA dosage: unknown. During the same period patient was treated with AMANTADINE, ROPINIROLE, HYDROCHLORIDE, CARBIDOPA AND LEVODOPA, SUSTAINED. Patient recovered.
HALO VISION : Visine Side Effects Report #5647447-3
Consumer or non-health professional from UNITED STATES reported VISINE A problem on Feb 15, 2008. Male patient was treated with VISINE A. After drug was administered, patient experienced the following problems/side effects: eye burns, eye pain, halo vision, vision blurred, . VISINE A dosage: unknown. Patient recovered.
HALO VISION : Byetta Side Effects Report #5650179-9
BYETTA problem was reported by a Consumer or non-health professional from UNITED STATES on Dec 23, 2007. Female patient, 59 years of age, was diagnosed with type 2 diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: blood glucose decreased, fatigue, halo vision, . BYETTA dosage: unknown. During the same period patient was treated with METFORMIN. Patient recovered.
HALO VISION : Enbrel Side Effects Report #5555203-X
Consumer or non-health professional from UNITED STATES reported ENBREL problem on Aug 12, 2007. Female patient was diagnosed with rheumatoid arthritis and was treated with ENBREL. After drug was administered, patient experienced the following problems/side effects: cataract, cholecystectomy, halo vision, intraocular pressure increased, paraesthesia, photopsia, toothache, . ENBREL dosage: unknown. Patient recovered.
HALO VISION : Vesicare Side Effects Report #5487206-8
VESICARE problem was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2007. Female patient, 56 years of age, was diagnosed with incontinence and was treated with VESICARE. After drug was administered, patient experienced the following problems/side effects: balance disorder, dizziness, halo vision, vertigo, vision blurred, . VESICARE dosage: 5 MG, UID/QD; 5 MG, UID/QD, ORAL. During the same period patient was treated with CELEBREX. Patient recovered.